Domain Registrar Freename Secures $6.5 Million in Series A Funding Led by Entrée Capital
ChainCatcher reports that, according to Finsmes, Zurich-based domain registrar Freename has announced the completion of a $6.5 million Series A funding round, led by Entrée Capital with participation from Polymorphic Capital. Seed round investors Sparkle Ventures, Blockchain Founders Fund, and Golden Record Ventures also continued to invest. Angel investors in this round include Mike Lobanov, co-founder of Target Global, the Rashwan Family Office, and former Custody CEO of a major exchange, Aaron Schnarch.
Freename, led by CEO Davide Vicini and COO Mattia Martone, is dedicated to bridging traditional internet and blockchain through its proprietary DNS technology, enabling users to create custom top-level domains and profit from the sale of subdomains.
According to Web3 asset data platform RootData, Freename is a TLD (top-level domain) and domain registration platform that allows users to search for and register/create any type of TLD. On Freename, users can build their own Web3 domain name ecosystem and earn passive income from royalties.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
The White House did not intervene in the decision-making of Nvidia's board of directors.
Crypto prices
More
